NellOne Therapeutics

NellOne is an early-stage biopharmaceutical company using the talented protein to create a new future for regenerative medicine. The protein, NELL-1 (Neural EGF-like molecule), is a naturally secreted human protein that triggers multiple processes of tissue growth and maturation during development and after injury. NellOne Therapeutics holds dozens of patents in eight countries and regions and is working with partners to develop therapies that leverage the therapeutic potential of NELL-1 in various ways.